| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,762 |
7,945 |
$754K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,136 |
4,752 |
$500K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,174 |
2,047 |
$206K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,038 |
1,612 |
$105K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,277 |
1,001 |
$67K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,925 |
2,670 |
$60K |
| 36415 |
Collection of venous blood by venipuncture |
3,869 |
3,177 |
$57K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
399 |
323 |
$34K |
| 80053 |
Comprehensive metabolic panel |
4,526 |
3,853 |
$33K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,034 |
4,241 |
$30K |
| 71045 |
Radiologic examination, chest; single view |
4,895 |
3,748 |
$26K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
672 |
575 |
$24K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,758 |
1,351 |
$23K |
| 81001 |
|
2,594 |
2,338 |
$18K |
| 84484 |
|
1,634 |
1,255 |
$17K |
| 82553 |
|
1,716 |
1,334 |
$16K |
| 82550 |
|
1,769 |
1,354 |
$16K |
| 87430 |
|
1,488 |
1,419 |
$11K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
151 |
125 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
722 |
648 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,818 |
1,682 |
$7K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
793 |
728 |
$6K |
| 83880 |
|
183 |
143 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
485 |
425 |
$4K |
| 83735 |
|
437 |
383 |
$4K |
| 80305 |
|
307 |
286 |
$4K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
331 |
289 |
$3K |
| 85610 |
|
191 |
168 |
$3K |
| 85730 |
|
116 |
99 |
$2K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
398 |
353 |
$2K |
| 83690 |
|
155 |
139 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
23 |
14 |
$1K |
| 81025 |
|
1,278 |
1,192 |
$1K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
43 |
38 |
$880.15 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
647 |
598 |
$836.83 |
| 73130 |
|
88 |
70 |
$713.37 |
| 73630 |
|
13 |
12 |
$649.70 |
| 85378 |
|
15 |
12 |
$643.27 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
33 |
25 |
$633.55 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
53 |
39 |
$478.16 |
| 73030 |
|
15 |
13 |
$471.87 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
13 |
12 |
$465.01 |
| J1094 |
Injection, dexamethasone acetate, 1 mg |
26 |
25 |
$277.30 |
| 83605 |
|
15 |
12 |
$203.60 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
29 |
24 |
$170.59 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18 |
13 |
$104.20 |
| 73564 |
|
18 |
13 |
$47.45 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
50 |
50 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
52 |
50 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
112 |
108 |
$0.00 |
| 85007 |
|
26 |
25 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12 |
12 |
$0.00 |